Imagion Biosystems Ltd (ASX:IBX) Share Price

Company Profile

Business description
Imagion Biosystems Ltd operates in the field of non-invasive detection of specific solid tumor cancers by use of magnetic nanoparticles. Its principal continuing activities consisted of Nanotechnology; Biotechnology; Cancer Diagnostics; and Medical Imaging using Magnetic Resonance and Superparamagnetic Relaxometry. The company only operating segment - Research and Development. Its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics, and medical imaging using Superparamagnetic Relaxometry. In addition, the company is engaged in the research and development of its clinical phase lead product which is intended for the detection and staging of metastatic HER2 breast cancer.
Contact
96-100 Albert Road
Level 4
South MelbourneVIC3205
AUS
T: +61 396927222
https://www.imagionbiosystems.com
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees

Recommended

Allegations that the Chinese government told steel mills to stop buying from BHP shake markets.

Jon Mills, CFA | 08 October 2025

Charts from the Australian Dividend Outlook show the sectors where they are abundant.

Shani Jayamanne | 08 October 2025

Investors may be too pessimistic about this industry.

Jon Mills, CFA | 07 October 2025

Index	Last price	Change	% Change
All Ordinaries	9,276.60	19.90	-0.21%
CAC 40	8,064.64	4.51	0.06%
DAX 40	24,667.25	70.12	0.29%
Dow JONES (US)	46,601.78	1.20	-0.00%
FTSE 100	9,505.13	43.74	-0.46%
HKSE	26,752.59	76.87	-0.29%
NASDAQ	23,043.38	255.02	1.12%
Nikkei 225	48,580.44	845.45	1.77%
NZX 50 Index	13,570.86	2.38	0.02%
S&P 500	6,753.72	39.13	0.58%
S&P/ASX 200	8,969.80	25.20	-0.28%
SSE Composite Index	3,933.97	51.20	1.32%